Gains in the current understanding of managing neovascular AMD with brolucizumab

ConclusionProgress has been made in understanding how to mitigate IOI-related adverse events following treatment  with brolucizumab.
Source: Journal of Ophthalmic Inflammation and Infection - Category: Opthalmology Source Type: research